Program Announcement: PAR-22-123
The BPI Funding Opportunity Announcement encourages bioengineering applications that will accelerate the development and adoption of promising tools and technologies that can address important biomedical problems. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies, and engage biomedical researchers or clinicians throughout the project. The goal of the program is to support projects that can realize meaningful solutions within 5 – 10 years.
Applicants planning to submit a BPI application with direct costs exceeding $500,000 in any one year are reminded that they must submit a white paper (see below) and seek written agreement from the NIBIB staff at least 6 weeks prior to the application receipt date. Applicants are encouraged to contact the NIBIB staff well in advance of the 6-week deadline to discuss their planned application.
Accessibility remediation for these forms is underway. In the interim, please contact Guoying Liu at email@example.com for assistance.
NOTE: NIBIB’s policy (that does not apply to NCI, NEI, NIA) is to only consider applications with a maximum budget of $600k/year for a maximum of 5 years. If you are considering applying to the other participating institutes (NCI, NEI, NIA), please contact the contacts referenced at the bottom of this web page for any conditions that apply to their institute-specific funding policies.
Areas of high programmatic interest include:
- intelligent systems design and smart modeling
- enabling nanotechnologies for designed drug and gene delivery vehicles
- in vivo optical imaging
- activatable imaging agents
- multiscale modeling in biomedical systems
- sensor and lab-on-a-chip devices for point-of-care testing
- imaging informatics
- development of engineered 3D human tissue model systems
- image-guided interventions
- in vivo microimaging of internal organs
- techniques for characterization and modification of biomaterial interfacial properties
- high-field and high speed (parallel) MRI
- high-frequency and very high-frequency ultrasound imaging and other applications
- novel sensing technologies
- enabling technologies for tissue engineering and regenerative medicine
- high-intensity focused ultrasound (HIFU) therapies or interventions
- computational analysis and simulation methods
- improvement of radiological diagnostics, image-guided therapies, and human health
- clinical decision-making support systems
- in-home treatment monitoring
- next-generation intelligent image and data analysis tools
- mobile health.
- new technologies enabling direct imaging of targeted radio-therapies
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) PAR-22-123
Contacts and Additional Information
Find points of contact for all participating NIH Institutes and Centers at Scientific and Financial Contact for NIH Bioengineering Program Announcements.